MetroLoft, a prominent developer known for converting office spaces into luxury residential buildings in New York City, is currently under intense scrutiny following a structural issue at its former Pfizer headquarters conversion project. This incident, which involved buckling support beams and sagging floors, prompted a vacate order and an investigation by the Department of Buildings (DOB). While MetroLoft founder Nathan Berman downplayed the event as a "freak accident," the incident has drawn significant attention to the safety of office-to-residential conversions in the city.
The company is also facing multiple lawsuits and has a history of construction defects and violations. Notably, a condo board at 443 Greenwich St., a star-studded building previously converted by MetroLoft, is suing the developer for over $376 million, alleging "life-threatening shortcuts" and structural flaws including leaking roofs and crumbling walls. The initial claim of this lawsuit was $250 million. Another construction company sued MetroLoft in 2023 for over $200,000 in unpaid invoices for work at a building on 87th Street.
DOB records reveal a pattern of violations across MetroLoft's projects. The former Pfizer HQ site alone had 22 open violations, including an emergency stop work order. Other projects, such as the 25 Water St. conversion, one of the largest in the U.S., had 8 open violations with 42 previously resolved. The 111 Wall St. project had 10 open violations, with 18 resolved, including incidents like a heavy object falling through five floors. Overall, MetroLoft carries 40 open violations on three active properties. The DOB has mandated a third-party engineer to conduct a forensic evaluation of the Pfizer HQ site.
The structural issues at the former Pfizer headquarters, a massive 1.3 million square feet conversion project aiming for 1,600 luxury apartments, have raised concerns about the wider trend of office-to-residential conversions in NYC. This trend is driven by high office vacancy rates post-COVID-19 and city initiatives to address housing shortages through zoning reforms and tax incentives. Mayor Zohran Mamdani emphasized the need for such conversions to be conducted safely and accountably, implying that the MetroLoft incident represents a breakdown in this process rather than an inherent risk of conversions. MetroLoft has stated that the issues affect a small fraction of the building and it remains on schedule.
MetroLoft, which has converted over 8 million square feet across 16 projects since 1997, has increasingly faced issues with larger properties. The building at the former Pfizer headquarters, a joint venture with David Werner, secured a $700 million construction loan from Madison Realty Capital, a record for a residential conversion project in New York. The incident occurred during the construction of an 11-story addition, which initial analyses suggest overstressed the existing 37 floors, causing shifting and bending of support structures. Developer MetroLoft has disputed accusations in current lawsuits and stated that reports of collapse risk were inaccurate.
